call us today
1.000.000.0000
1.000.000.0000
Dr. Blumenschine is an Associate Professor at the Department of Thoracic Head and Neck Medical Oncology, Division of Cancer Medicine at the University of Texas M.D Anderson Cancer Center, in Houston, city of Texas
He graduated University of Texas Medical School at Houston, Texas. His postgraduate training are: clinical residency at the University of Texas Health Science Center at Houston, TX, for internal medicine; clinical fellowship at University of Texas M.D Anderson Cancer Center, in Houston, TX at the department of Medical Oncology.
His research interests includes: therapies for non-small cell lung cancer, small cell lung cancer, head and neck cancers, phase I drug development.
He is developing multimodality for lung, head and neck cancer, using different combinations of drugs administrated in the first phase of the disease.
A part of his clinical research includes evaluation of biological correlates to improve the understanding of the mechanism by which this drugs work, in order to design better treatments form mesothelioma lung cancer and other types of cancer.
Dr. Blumenschine is the leader of a multi-center phase II study of Cetuxumab in combination with chemotherapy. This study is sponsored by The National Cancer Institute, in which Dr. Blumenschine is the principal investigator.
Contact mesothelioma doctors today and start with the right treatment!
Mesothelioma (cancer of the mesothelium) is a disease in which cells of the mesothelium become abnormal and divide without control or order. They can invade and damage nearby tissues and organs. Cancer cells can also metastasize (spread) from their original site to other parts of the body. Most cases of mesothelioma begin in the pleura or peritoneum.
Test Test